Trial Profile
Scar Formation and Quality of Life Assessment in Subjects (Adults and Children) Following Treatment With Debrase Compared to Standard of Care (SOC).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2017
Price :
$35
*
At a glance
- Drugs Peptide hydrolases (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors MediWound
- 31 Oct 2017 Status changed from not yet recruiting to completed.
- 13 May 2011 New trial record